RedHill Biopharma (RDHL) Invested Capital (2018 - 2025)
RedHill Biopharma (RDHL) posted quarterly Invested Capital of $14.8 million for Q4 2025, up 22.92% year-over-year from $12.0 million in Q4 2024, and up 22.92% quarter-over-quarter from $12.0 million in Q4 2024.
RedHill Biopharma (RDHL) Invested Capital (2018 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Invested Capital for 8 consecutive years, with $14.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Invested Capital rose 22.92% year-over-year to $14.8 million; the TTM figure through Dec 2025 stood at $26.8 million (up 103.1% YoY), while the FY2025 annual figure was $14.8 million, up 22.92% from the prior year.
- Invested Capital improved to $14.8 million in Q4 2025 per RDHL's latest filing, from $12.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $115.2 million in Q4 2022 and bottomed at $1.2 million in Q4 2023.
- Historically, Invested Capital has averaged $52.1 million across 5 years, with a median of $49.2 million in 2021.
- Annual changes were most pronounced in 2023 — Invested Capital slumped 98.98% — and 2024, when it jumped 924.55%.
- RedHill Biopharma's Invested Capital stood at $83.6 million in 2021, then surged by 37.79% to $115.2 million in 2022, then plunged by 98.98% to $1.2 million in 2023, then surged by 924.55% to $12.0 million in 2024, then climbed by 22.92% to $14.8 million in 2025.
- Business Quant data shows RDHL's Invested Capital at $14.8 million in Q4 2025, $12.0 million in Q4 2024, and $1.2 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 630.00 Mn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | 14.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.77 Mn |
| Dec 31, 2024 | 12.02 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 115.22 Mn |
| Jun 30, 2022 | 85.51 Mn |
| Dec 31, 2021 | 83.62 Mn |
| Dec 31, 2020 | 81.39 Mn |
| Dec 31, 2019 | 3.82 Mn |
| Dec 31, 2018 | 1.67 Mn |